RNA affecting skin cancer progression discovered

RNA affecting skin cancer progression discovered

Discovery about how cancer cells hide from the immune system could improve treatments "The majority of the human genome contains genes that do not produce protein, but their role as regulators of cellular functions is still essential. Long non-coding RNAs are a largely unknown set of RNAs and recent studies have found that they play a role in regulating signaling pathways, particularly in cancer", says researcher Minna Piipponen, one of the authors of the study. Thus, RNA molecules could be utilized in cancer diagnostics as specific marker molecules and as targets for new therapies. PRECSIT regulates the growth and spread of squamous cell carcinoma The study found that expression of a new long non-coding RNA in cancer cells of squamous cell carcinoma was elevated compared to healthy skin. The study also showed that expression of PRECSIT is regulated by the tumor suppressor gene p53, which is inactivated by mutations in most squamous cell carcinomas. The researchers also discovered that PRECSIT promotes the invasion of cancer cells by increasing the production of extracellular matrix cleaving proteolytic enzymes via the STAT3 signaling pathway. Based on its expression and mechanism of action, this long non-coding RNA was named PRECSIT (p53 regulated carcinoma-associated STAT3-activating long intergenic non-protein coding transcript). "Long non-coding RNAs are currently a hot topic in cancer research worldwide as they could potentially be used as new biomarkers and specific therapeutic targets in different cancers. PRECSIT provides new insight into the role of long non-coding RNA molecules in the progression of squamous cell carcinoma", Piipponen concludes. The results of the study were published in the February 2020 issue of the American Journal of Pathology . Source: University of Turku Journal reference: Piipponen, M., et al. (2020) p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling. American Journal of Pathology . doi.org/10.1016/j.ajpath.2019.10.019 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More